Cite
Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group.
MLA
Teke, Kerem, et al. “Analysis of Risk Factors for Cancer-Specific Survival in Neoadjuvant Chemotherapy Nonresponsive Disease of Muscle-Invasive Bladder Cancer: A Multicentre Study from the Turkish Urooncology Association Bladder Tumor Study Group.” Urologic Oncology, Sept. 2024. EBSCOhost, https://doi.org/10.1016/j.urolonc.2024.09.006.
APA
Teke, K., Yılmaz, H., Baltacı, S., Akgül, M., Şahin, B., Türkeri, L., Bozkurt, O., Yücetaş, U., Aslan, G., Bolat, D., İzol, V., Özkan, T. A., & Eskiçorapçi, S. (2024). Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group. Urologic Oncology. https://doi.org/10.1016/j.urolonc.2024.09.006
Chicago
Teke, Kerem, Hasan Yılmaz, Sümer Baltacı, Murat Akgül, Bahadır Şahin, Levent Türkeri, Ozan Bozkurt, et al. 2024. “Analysis of Risk Factors for Cancer-Specific Survival in Neoadjuvant Chemotherapy Nonresponsive Disease of Muscle-Invasive Bladder Cancer: A Multicentre Study from the Turkish Urooncology Association Bladder Tumor Study Group.” Urologic Oncology, September. doi:10.1016/j.urolonc.2024.09.006.